靶向动脉粥样硬化可示踪的抗自由基和抗炎损伤聚阳离子核酸递送系统研究
批准号:
52073310
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
刘尊敬
依托单位:
学科分类:
生物医用有机高分子材料
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
刘尊敬
中文摘要
自由基损伤和炎性损伤是促进动脉粥样硬化(AS)病情进展最为重要的病理机制。课题申请者前期研究表明利用聚阳离子核酸载体负载靶基因的血管支架具有改善支架后血管再狭窄的功能。本研究以前期工作为基础,以甲基丙烯酸缩水甘油酯、氨基TEMPO、乙醇胺为基本反应物,通过可控聚合、氨基与环氧的开环反应和酰胺化后修饰引入靶向多肽,构建具有核磁成像功能可活体示踪、清除自由基的靶向聚阳离子核酸递送载体。利用该核酸递送载体修饰负载能够对抗AS病理过程、减轻AS动脉损伤的抗炎蛋白IL-10、ACE2、AnxA1质粒,将其递送至AS局部病变组织。最终构建出可以通过抗炎和清除自由基联合机制靶向AS病变部位、可以活体示踪的新型多功能聚阳离子核酸递送体系。预期研究结果对于提高多功能基因递送载体的理论创新水平和实际探索应用都有很大的学术价值,同时为动脉粥样硬化的治疗提供新的思路,对推动医用材料学科的发展也具有一定的意义。
英文摘要
Free radical injury and inflammatory injury are the most important pathological mechanisms of atherosclerosis (AS), which accelerate the progression of atherosclerosis. Preliminary study showed that the vessel stent loaded with target gene by polycationic acid delivery vector could improve vessel restenosis after stent. This study is based on previous research work,glycidyl methacrylate, amino TEMPO, and ethanolamine were used as basic reactive substances. Targeted polypeptides, which were made through controllable polymerization, ring-opening reaction of amino groups and epoxy, and modification after amidation, were used to construct a targeted polycationic nucleic acid delivery vector with MRI imaging function for in vivo tracking and scavenging free radicals against oxidative damage. Using this nucleic acid delivery vector to modify the load can counteract the pathological process of AS and reduce AS arterial damage associated anti-inflammatory protein IL-10, ACE2, AnxA1 functional gene plasmids delivered to AS local lesion tissue. Eventually a new multifunctional polycationic nucleic acid delivery system was constructed, which can be applied to AS treatment through the combined mechanisms of anti-inflammatory and anti-free radicals and be traced in vivo. The expected results have great academic value for improving the theoretical innovation level and exploring practical application of multifunctional gene delivery vectors. And it has widely prospect in clinical practice and can provide a new idea for the treatment of AS. In addition, it has important significance for further promoting the development of medical polymer science.
动脉粥样硬化是心脑血管疾病的重要病理基础,其发病机制涉及自由基损伤和炎性反应。本项目构建了一种靶向动脉粥样硬化病变部位、具有抗自由基和抗炎功能的聚阳离子核酸递送系统,并探索其在核磁成像及临床应用中的潜力。研究通过可控聚合技术,成功合成了分子量可控的聚甲基丙烯酸缩水甘油酯(PGMA),并引入自由基清除基团(TEMPO)和靶向多肽(VHPK),开发出功能性阳离子聚合物PGED-TEMPO-VHPK。体外实验表明,该聚合物具有低细胞毒性、高效基因转染能力,并在LPS等诱导的炎症细胞模型中展现出显著的自由基清除和抗炎效果。体内实验进一步验证了其在APOE-/-小鼠模型中的靶向递送能力、抗动脉粥样硬化效果以及核磁成像能力,实现了对病变血管的高对比度成像和斑块的显著抑制。此外,课题组还探索了高分辨核磁成像技术在评估颅内动脉粥样硬化及其相关的临床疾病中的应用价值,为脑血管疾病的精确诊断和个体化治疗提供了新的思路。
利用新型非病毒基因载体负载靶基因的血管支架对颈动脉支架内再狭窄治疗作用的研究
-
批准号:31771045
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2017
-
负责人:刘尊敬
-
依托单位:
基于PPARγ-HSP70通路探讨姜黄素对阿尔茨海默病的治疗作用及机制分析
-
批准号:81373794
-
项目类别:面上项目
-
资助金额:68.0万元
-
批准年份:2013
-
负责人:刘尊敬
-
依托单位:
姜黄素(PPARγ天然激活剂)纳米乳粒和载PPARγ基因支架的应用防治颈动脉支架后再狭窄的实验研究
-
批准号:81173595
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2011
-
负责人:刘尊敬
-
依托单位:
姜黄素抗脑缺血病理损伤的PPARgamma靶向路径确认
-
批准号:30973900
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2009
-
负责人:刘尊敬
-
依托单位:
国内基金
海外基金